Technical Analysis for SRNE - Sorrento Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 2.3 1.32% 0.03
SRNE closed up 1.32 percent on Friday, January 18, 2019, on 89 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical SRNE trend table...

Date Alert Name Type % Chg
Jan 18 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Jan 18 Narrow Range Bar Range Contraction 0.00%
Jan 18 NR7 Range Contraction 0.00%
Jan 18 Stochastic Reached Oversold Weakness 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Oversold Stochastic Weakness 0.00%
Jan 17 Inside Day Range Contraction 1.32%
Jan 17 Wide Bands Range Expansion 1.32%
Jan 16 20 DMA Resistance Bearish 0.88%
Jan 16 Wide Bands Range Expansion 0.88%

Older signals for SRNE ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Sorrento Therapeutics, Inc., a development stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel and proprietary biotherapeutics for the treatment of cancer, inflammation, metabolic, and infectious diseases in the United States. The company's G-MAB, a human antibody library platform, facilitates the rapid identification and isolation of highly specific antibody therapeutic product candidates that bind to disease targets appropriate for antibody therapy. Its human antibody library technology is used to construct large human antibody libraries. It has license agreement with OPKO Health, Inc. to develop, manufacture, use, market, sell, offer to sell, import, and export certain products related to the development, manufacture, marketing, and sale of drugs for ophthalmological indications. Sorrento Therapeutics, Inc. is based in San Diego, California.
Is SRNE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 10.65
52 Week Low 1.95
Average Volume 1,499,501
200-Day Moving Average 5.0345
50-Day Moving Average 2.8934
20-Day Moving Average 2.3695
10-Day Moving Average 2.428
Average True Range 0.2145
ADX 13.58
+DI 20.3609
-DI 19.8215
Chandelier Exit (Long, 3 ATRs ) 2.2665
Chandelier Exit (Short, 3 ATRs ) 2.5935
Upper Bollinger Band 2.7601
Lower Bollinger Band 1.9789
Percent B (%b) 0.41
BandWidth 32.968981
MACD Line -0.1384
MACD Signal Line -0.1522
MACD Histogram 0.0138
Fundamentals Value
Market Cap 158.63 Million
Num Shares 69 Million
EPS -0.66
Price-to-Earnings (P/E) Ratio -3.50
Price-to-Sales 10.91
Price-to-Book 1.87
PEG Ratio -0.06
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.45
Resistance 3 (R3) 2.44 2.39 2.43
Resistance 2 (R2) 2.39 2.35 2.39 2.42
Resistance 1 (R1) 2.34 2.32 2.37 2.35 2.41
Pivot Point 2.29 2.29 2.30 2.29 2.29
Support 1 (S1) 2.24 2.25 2.27 2.25 2.19
Support 2 (S2) 2.19 2.22 2.19 2.18
Support 3 (S3) 2.14 2.19 2.18
Support 4 (S4) 2.15